Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback